Aisthesis Medical

The AI engine Fit Assessment

Beta

The company will be attending the 2024 Health Tech Forward Event

Blurb

Aisthesis Medical specializes in providing AI-driven decision support for acute care to prevent complications and enhance patient outcomes.

HQ Location

London (United Kingdom)

Founded

2022

Employees

1 - 10

Total funding raised

$1.57M

Funding Status

Pre-Seed, $1.20M, October 1, 2025

Aisthesis Medical is a MedTech startup revolutionizing acute and critical care with VIOSync, an AI-powered clinical decision-support system that predicts sepsis, hypotension, and multi-organ dysfunction before clinical deterioration occurs. By integrating EHRs, wearable devices, and bedside monitors, VIOSync creates a digital twin for each patient, providing real-time, explainable predictive analytics to enhance decision-making.



Designed for seamless adoption, VIOSync not only detects risks early but also aligns with evidence-based protocols to guide interventions, improving patient outcomes, reducing ICU admissions, and streamlining hospital workflows. With a focus on high-risk, undermonitored settings, we are redefining how hospitals predict and manage critical conditions before they escalate.